A Semiconductor Waveguide-Type Optical Frequency Shifter
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-08-01
著者
-
Tanaka Shigehisa
Rwcp Optoelectronics Hitachi Laboratory Central Research Laboratory Hitachi Ltd.
-
Inoue Hiroaki
Department Of Animal Science Obihiro University Of Agriculture And Veterinary Medicine
-
NISHIMURA Shinji
RWCP Optoelectronics Hitachi Laboratory, Central Research Laboratory, Hitachi, Ltd.
-
INOUE Hiroaki
RWCP Optoelectronics Hitachi Laboratory, Central Research Laboratory, Hitachi, Ltd.
-
Nishimura Shinji
Rwcp Optoelectronics Hitachi Laboratory Central Research Laboratory Hitachi Ltd.
関連論文
- Cu-NMR Study on Field-Induced Phase Transitions in Quantum Spin Magnet NH_4CuCl_3(Magnetization Plateaus, Field-Induced Phase Transitions and Dynamics in Quantum Spin Systems)
- Preparation and Characteristics of Antibacterial Sepiolite Containing Povidone-Iodine as a Useful Pharmaceutical Product for Patient Care
- 性転換法によるイエバエ,Musca domestica L.,の常染色体上の雄性決定因子のマッピング〔英文〕
- Male crossing-over and location of the male determining factor on the third chromosome in a IIIM-type strain of the housefly
- イエバエの第1染色体上の雄性決定因子と雄における乗換え〔英文〕
- Effects of fasting and refeeding on plasma concentrations of leptin, ghrelin, insulin, growth hormone and metabolites in swine
- Effect of atropine and pyridostigmine on growth hormone response to GH-releasing peptide-2 and GH-releasing hormone in swine
- A Semiconductor Waveguide-Type Optical Frequency Shifter
- The effect of leukocyte function of streptozotocin-induced diabetes in naturally occurring gingivitis rat
- Light Intensity Stabilization Using Highly-Efficient Faraday Rotator
- イエバエMusca domesticaの第4染色体上の雄性決定因子の位置決定〔英文〕
- Molecular Chain Structure of $\alpha$-Sexithienyl on Ag(110) Observed by Scanning Tunneling Microscopy
- The Relationship between the Sialic Acid Concentrations in the Serum and Whole Saliva in Rats with Naturally Occurring Gingivitis.
- Mapping of autosomal male-determining factors of the housefly, Musca domestica L., by using a female-determining factor.
- Epirubicin/Cyclophosphamide followed by Docetaxel as Primary Systemic Therapy in Breast Cancer:–Phase II study, Final analysis–